Login / Signup

Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes.

Rosa LombardiLorena AiraghiGiovanni TargherGaetano ServiddioGabriele MaffiAlessandro MantovaniClaudio MaffeisAntonio ColecchiaRosanna VillaniLuca RinaldiEmanuela OrsiGiuseppina PisanoLuigi Elio AdinolfiSilvia FargionAnna Ludovica Fracanzani
Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Significant fibrosis, detected by FibroScan® , is independently associated with increased prevalence of macrovascular and microvascular complications, thus opening a new scenario in the use of this tool for a comprehensive evaluation of hepatic and vascular complications in patients with T2DM.
Keyphrases
  • liver fibrosis
  • risk factors
  • metabolic syndrome